Hinge Health (NYSE:HNGE) Trading 9.5% Higher on Earnings Beat

Hinge Health Inc. (NYSE:HNGE)’s share price shot up 9.5% on Wednesday following a better than expected earnings announcement. The company traded as high as $87.36 and last traded at $86.97. Approximately 1,235,878 shares were traded during trading, a decline of 18% from the average daily volume of 1,498,308 shares. The stock had previously closed at $79.42.

The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.31. The company had revenue of $212.82 million for the quarter. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.Hinge Health’s revenue for the quarter was up 53.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.59 earnings per share.

More Hinge Health News

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Strong second-quarter performance: Hinge Health reported $212.8 million in revenue, up 53% year over year, and earnings of $0.59 per share. That exceeded the $0.28 consensus estimate cited by MarketBeat, although Zacks characterized the result as in line with its own consensus. The company also said free cash flow more than tripled from the prior year. Hinge Health reports record second-quarter 2026 financial results
• Positive Sentiment: Above-consensus third-quarter outlook: Management forecast third-quarter revenue of $223 million to $225 million, well above the roughly $211 million analyst consensus. The guidance reinforces expectations for continued strong growth. Hinge Health earnings conference call
• Positive Sentiment: Analyst target raised: Needham increased its price target from $76 to $97 and assigned a “Buy” rating, implying substantial upside from recent trading levels. Benzinga analyst update
• Positive Sentiment: Expansion into gastrointestinal care: Hinge Health agreed to acquire Cylinder Health for $105 million in cash. The deal is intended to add a virtual-first GI Care Program to its existing musculoskeletal and migraine offerings, expanding its addressable market. Hinge Health to acquire Cylinder Health
• Neutral Sentiment: CEO Daniel Perez’s earnings interview and the Q2 earnings call provide additional detail on the company’s operating performance, strategy and outlook. Daniel Perez Hinge Health CEO interview
• Negative Sentiment: Profitability remains a risk: Despite the quarterly EPS beat, Hinge Health continues to report a negative net margin and negative return on equity. The $105 million all-cash acquisition also creates execution and integration risks.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Truist Financial increased their price objective on shares of Hinge Health from $79.00 to $85.00 and gave the stock a “buy” rating in a research note on Thursday, June 11th. Royal Bank Of Canada restated an “outperform” rating and issued a $110.00 price target on shares of Hinge Health in a research note on Wednesday. Citigroup reiterated an “outperform” rating on shares of Hinge Health in a research report on Monday, July 27th. Zacks Research upgraded shares of Hinge Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hinge Health in a research note on Monday. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Hinge Health has a consensus rating of “Moderate Buy” and an average target price of $90.73.

Insider Activity at Hinge Health

In other Hinge Health news, Chairman Gabriel M.I. Mecklenburg sold 83,334 shares of Hinge Health stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $60.22, for a total value of $5,018,373.48. Following the sale, the chairman owned 83,334 shares of the company’s stock, valued at $5,018,373.48. The trade was a 50.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Insight Holdings Group, Llc sold 1,466,667 shares of the company’s stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $82.83, for a total value of $121,484,027.61. The SEC filing for this sale provides additional information. Insiders have sold a total of 3,766,556 shares of company stock valued at $290,713,052 in the last 90 days. 18.92% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Hinge Health

A number of institutional investors and hedge funds have recently modified their holdings of HNGE. Vista Investment Partners LLC bought a new position in shares of Hinge Health during the 2nd quarter valued at approximately $3,468,000. Assenagon Asset Management S.A. bought a new stake in Hinge Health in the second quarter worth $6,867,000. California State Teachers Retirement System boosted its stake in Hinge Health by 35.2% during the first quarter. California State Teachers Retirement System now owns 19,141 shares of the company’s stock worth $738,000 after buying an additional 4,986 shares during the period. Estuary Capital Management LP bought a new position in Hinge Health during the first quarter valued at $15,201,000. Finally, Lazard Asset Management LLC increased its position in Hinge Health by 0.6% during the first quarter. Lazard Asset Management LLC now owns 63,705 shares of the company’s stock valued at $2,456,000 after acquiring an additional 386 shares during the last quarter.

Hinge Health Stock Up 9.5%

The company’s 50 day moving average price is $74.52 and its two-hundred day moving average price is $54.18. The firm has a market cap of $6.73 billion, a PE ratio of -7.05 and a beta of 1.30.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.